NUCLEIC ACID THERAPEUTICS FOR RARE DISEASES (NAT-RD)
Publications (6)
filter_list
Drug Discovery
2023
-
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides
Nucleic acid therapeutics, Vol. 33, Núm. 1, pp. 1-16
-
Experimental Model Systems Used in the Preclinical Development of Nucleic Acid Therapeutics
Nucleic Acid Therapeutics, Vol. 33, Núm. 4, pp. 238-247
2022
-
Antisense RNA Therapeutics: A Brief Overview
Methods in Molecular Biology (Humana Press Inc.), pp. 33-49
-
Lessons learned from developing an oligonucleotide drug for a rare disease
RNA Therapeutics: The Evolving Landscape of RNA Therapeutics (Elsevier), pp. 121-137
2021
-
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
EMBO Molecular Medicine, Vol. 13, Núm. 4
2017
-
Delivery is key: lessons learnt from developing splice-switching antisense therapies
EMBO Molecular Medicine, Vol. 9, Núm. 5, pp. 545-557